Click2PrintAE®, an end-to-end digital workflow for 3D printed ocular prosthetics
Click2PrintAE®, an end-to-end digital workflow for 3D printed ocular prosthetics
批准号:
10071306
负责人:
金额:
$26.45万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Incorporated in 2016, Ocupeye are a UK-based SME with an innovative, visionary team of assistive devices innovators led by design, engineering, and business experts. Our strong ambition to drive positive change within the healthcare industry has led us on a journey to create a 3D printing process for prosthetic eyes that not only reduces hospital costs and labour time, but prioritises patient comfort, satisfaction, and prosthetic fit.Over 8 million people worldwide and 70k in the UK wear a prosthetic eye \[Moorfields Eye Charity\]. Despite technological advancements elsewhere in healthcare, the current process to supply ocular prosthetics to patients has remained largely unchanged for over 70 years, with ocular prosthetics currently moulded, shaped, painted, and fitted individually by hand with techniques from the 1950s. The process is invasive and often traumatic for patients, particularly for children, with alginate injections required to make wax patterns for patient's eye shapes. Prosthetics are then hand-painted, assembled, and polished, which is time-consuming and requires highly skilled resource. Waiting list time been exacerbated by COVID-19, with waiting list numbers for elective care increased from 4.4 million to 6 million people \[NHS Delivery Plan\]. This greatly impacts patient care, satisfaction, and overall quality of life.To address these issues, Ocupeye will bring to market the world's first end-to-end digital process for the 3D printing and manufacture of prosthetic eyes. The process will be non-invasive and no-touch to patients and significantly reduce the extortionate waiting list time from 60 weeks to a 3-week turnaround, whilst delivering a much-needed, innovative life sciences product into healthcare more quickly and effectively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
真菌特异的内吞作用相关蛋白End3发挥作用的结构研究
-
批准号:32000859
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王冬立
-
依托单位:
峨眉山玄武岩喷发持续时间的研究:来自古地磁学的约束
-
批准号:41804068
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2018
-
负责人:徐颖超
-
依托单位:
从PBMC-β-END-μ-阿片受体途径探讨华蟾素治疗癌痛的外周机制
-
批准号:81173612
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:陈涛
-
依托单位:
晚期糖基化终产物受体与视网膜母细胞瘤蛋白在前列腺癌细胞中的相互作用及意义
-
批准号:30700835
-
项目类别:青年科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:赵善超
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: